MAXNAZOLE

This brand name is authorized in Nigeria.

Active ingredients

The drug MAXNAZOLE contains one active pharmaceutical ingredient (API):

1	Ketoconazole UNII R9400W927I - KETOCONAZOLE
	Ketoconazole is an imidazole-dioxolane antimycotic, active against yeasts, including Malassezia and dermatophytes.
	Read more about Ketoconazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-3350	Cream	MAXNAZOLE CREAM CREAM 2% 30G	MAXNAZOLE CREAM KETOCONAZOLE 2% W/W 1 Ketoconazole USP 15.00 2 Methyl Paraben BP 1.519 3 Propyl Paraben BP 0.524 4 Disodium EDTA BP 0.748 5 Cetostearyl Alcohol BP 540.15 6 Cetomacragol 1000 BP 13.485 7 Light Liquid Paraffin BP 45.00 8 White Soft Paraffin BP 90.00 9 Isopropyl Myristate BP 15.00 10 Butylated Hydroxy Toluene BP 0.104 11 Sodium Dihydrogen Phosphate BP 2.269 12 Propylene Glycol BP 75.00 13 Purified Water BP/IH q. s. b4-3350 Drugs Imported Products 30G Prescription Only Medicine (POM) 15/01/2020 APHANTEE PHARM NIGERIA LTD, SUITE FF 11, PACIFIC COMPLEX AWKA ROAD ONITSHA ANAMBRA 8077261675 aphanteepharm@yahoo.com MAXHEAL PHARMACEUTICALS ( INDIA) LTD,., J-7,MIDC TArapur Industrial Area,Boisar 401506, Maharashtra, India , India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D01AC08	Ketoconazole	D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-3350